Y. Zhao et Hw. Davis, THROMBIN-INDUCED PHOSPHORYLATION OF THE MYRISTOYLATED ALANINE-RICH C-KINASE SUBSTRATE (MARCKS) PROTEIN IN BOVINE PULMONARY-ARTERY ENDOTHELIAL-CELLS, Journal of cellular physiology, 169(2), 1996, pp. 350-357
Myristoylated alanine-rich C kinase substrate (MARCKS) is a prominent
protein kinase C (PKC) substrate that is targeted to the plasma membra
ne by an aminoterminal myristoyl group. In its nonphosphorylated form,
MARCKS cross-links F-actin and binds calmodulin (CaM) reciprocally. H
owever, upon phosphorylation by PKC, MARCKS releases the actin or CaM.
MARCKS may therefore act as a CaM sink in resting cells and regulate
CaM availability during cell activation. We have demonstrated previous
ly that thrombin-induced myosin light chain (MLC) phosphorylation and
increased monolayer permeability in bovine pulmonary artery endothelia
l cells (BPAEC) require both PKC- and CaM-dependent pathways. We there
fore decided to investigate the phosphorylation of MARCKS in BPAEC to
ascertain whether this occurs in a temporally relevant manner to parti
cipate in the thrombin-induced events. MARCKS is phosphorylated in res
ponse to thrombin with a time course similar to that seen with MLC. As
expected, MARCKS is also phosphorylated by phorbol 12-myristate 13 ac
etate (PMA), a PKC activator, but with a slower onset and more prolong
ed duration. Bradykinin also enhances MARCKS phosphorylation in BPAEC,
but histamine does not. MARCKS is distributed evenly between the memb
rane and cytosol in BPAEC, and neither thrombin nor PMA caused signifi
cant translocation of the protein. Specific PKC inhibitors attenuated
MARCKS phosphorylation by either thrombin or PMA. Since thrombin-induc
ed MLC phosphorylation is also attenuated by these inhibitors, MARCKS
may be involved in MLC kinase activation and subsequent BPAEC contract
ion. W7, a CaM antagonist, enhances the phosphorylation of MARCKS. Thi
s was expected since CaM binding to MARCKS has been shown to decrease
MARCKS phosphorylation by PKC. On the other hand, tyrosine kinase inhi
bitors, genistein and tyrphostin, attenuate MARCKS phosphorylation but
have no effect on MLC phosphorylation, suggesting that MARCKS may be
phosphorylated by kinases other than PKC. Phosphorylation of MARCKS ou
tside the PKC phosphorylation domain would not be expected to induce t
he release of CaM. These data provide support for the hypothesis that
MARCKS may serve as a regulator of CaM availability in BPAEC. (C) 1996
Wiley-Liss, Inc.